Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Adjust Your Daily Routine Simple routine adjustments can significantly impact digestive health while on Ozempic
Long-term safety, especially for repeated cosmetic use, is not well-established
News provided by Novo Nordisk 08 Jul, 2026, 09:22 CST Up to one in three participants on semaglutide 7.2 mg achieved at least 25% weight loss over 72 weeks Mean weight loss with semaglutide 7.2 mg reached 21%, reflecting overall treatment efficacy Up to 84% of weight loss was driven by reductions in fat mass, supporting meaningful improvements in body composition SINGAPORE, July 8, 2026 /PRNewswire/ -- Novo Nordisk announced an update to the Singapore label for semaglutide, approved in Singapore as Wegovy (semaglutide) injection, incorporating clinical evidence from the STEP UP trial in adults living with obesity without diabetes
Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: the Traumatic Life Events Questionnaire
They focus on sustainable habits rather than quick fixes
The GLP-1 receptor activation is reshaping your appetite neurocircuitry, slowing gastric emptying, and beginning to improve insulin sensitivity
